Whether sugar substitutes help or hurt blood sugar control in adults with prediabetes is not yet known, according to research reviewed by Gram. A new trial design will test four sweeteners at 25% of the FDA daily limit in 6-week controlled diets for adults 40 and older.
Many people with prediabetes use sugar substitutes like sucralose and aspartame, but scientists are not sure how these sweeteners affect blood sugar. According to research reviewed by Gram, a newly published study plan describes two controlled feeding trials designed to answer this question. Adults aged 40 and older with prediabetes will eat standardized meals for six weeks while receiving one of four common sweeteners or no sweetener at all. Researchers will measure blood sugar control, insulin response, markers of inflammation, and gut bacteria. This paper describes the plan only, so no results are available yet. Until the trials are finished, people with prediabetes should keep following their doctor’s advice about diet and sugar intake.
Key Statistics
A 2026 study protocol published in Contemporary Clinical Trials Communications describes two randomized trials that will test four non-sugar sweeteners in adults aged 40 and older with prediabetes, and no results have been reported yet.
The planned trials will give sweeteners at 25% of the U.S. Food and Drug Administration’s acceptable daily intake, adjusted for body weight, over a 6-week period with a 2-week lead-in diet.
Middle-aged and older adults make up about 50% of people with prediabetes, which is why researchers are focusing this trial on that age group.
The Quick Take
- What they studied: Do common sugar substitutes change how the body handles blood sugar and insulin in adults with prediabetes? Prediabetes means blood sugar is higher than normal but not yet high enough to be type 2 diabetes.
- Who participated: The study plans to enroll adults aged 40 and older who have prediabetes. The paper does not state how many people will take part.
- Key finding: This paper is a study plan, so it reports no results. It describes how researchers will test four sweeteners (sucralose, aspartame, acesulfame potassium, and saccharin) against a group that uses no sweetener.
- What it means for you: No new advice comes from this paper yet. If you have prediabetes, talk with your doctor or dietitian about which sweeteners, if any, fit your health plan. Watch for results from these trials before changing your habits based on this research.
The Research Details
This paper describes how researchers plan to run a study, not what they found. The plan includes two separate trials, each with three groups. Participants will be randomly assigned to a group, which means chance decides who gets which sweetener. This helps prevent differences between groups from being caused by the researchers’ choices or the participants’ own preferences.
In the first trial, one group receives sucralose, one receives aspartame, and a third group receives no sweetener. In the second trial, one group receives acesulfame potassium, one receives saccharin, and a third group receives no sweetener. Everyone will follow a standardized eating plan that includes the same amount of calories and reflects typical American eating patterns. The plan starts with a 2-week lead-in period, followed by 4 weeks of the sweetener intervention, for 6 weeks total.
The sweetener amount is set at 25% of the daily limit the U.S. Food and Drug Administration considers safe, adjusted for each person’s body weight. The main measurements will track blood sugar and insulin over a 24-hour period. Researchers will also measure inflammation markers in the blood and changes in gut bacteria.
Randomized controlled trials are one of the strongest ways to test whether something causes a change. Because each sweetener is tested separately, researchers can tell which sweetener has which effect, rather than lumping them together. Many earlier studies were short, used healthy volunteers, or tested several sweeteners at once, which made their findings hard to apply to people with prediabetes. This design is meant to address those gaps.
The study design is strong for this question because it uses random assignment, a no-sweetener comparison group, and a controlled diet. Controlled diets reduce the chance that other food choices affect the results. However, this paper is only a design plan. It does not state the number of participants, and the journal’s impact factor is not provided here. Readers should judge the study’s reliability only after the final results are published and checked by other scientists.
What the Results Show
This paper does not report any results. It explains what the researchers plan to measure. The main measure is 24-hour blood sugar control and insulin sensitivity. Insulin sensitivity describes how well the body’s cells respond to insulin, the hormone that moves sugar out of the blood. Researchers will compare each sweetener group with the group that uses no sweetener under the same diet conditions.
The second set of measures covers inflammation and gut bacteria. Inflammation markers such as TNF-α and MCP-1 are signals the body produces when it is under stress. Gut bacteria are the microbes that live in the digestive system, and their balance may influence metabolism. The paper lists these as secondary outcomes, meaning they add detail to the main question.
Because the trials are still a plan, no effects of sucralose, aspartame, acesulfame potassium, or saccharin on blood sugar have been shown in this paper. Any claims about these sweeteners helping or harming blood sugar would go beyond what this document supports.
The paper does not include secondary results. It identifies two secondary areas that researchers plan to study: inflammation and gut microbiome composition. These areas matter because earlier research has raised questions about whether sweeteners might affect gut bacteria, which could in turn affect blood sugar. The trials are designed to examine that possibility directly rather than rely on guesses.
The paper explains that earlier research on sugar substitutes has produced mixed results. Past trials were often short, used inconsistent amounts of sweetener, enrolled mostly healthy adults, or studied sweeteners only in groups. Because of these differences, the authors say it has been hard to set clear intake recommendations. This new design targets those gaps by focusing on people with prediabetes and testing each sweetener separately. It does not yet add new evidence to the existing body of research.
Because this is a study plan, the main limitation is that no data exist yet. The paper also does not state how many people will be enrolled, which affects how confident researchers can be in their findings. Six weeks is a relatively short period, so the trials cannot show whether effects last for months or years. The sweetener doses are based on a percentage of the FDA’s safe daily limit, so the results may not apply to people who consume much larger amounts. Finally, the trials use controlled meals, which makes them more precise but less like everyday life.
The Bottom Line
Confidence level: low for any conclusion about sweeteners, because no results have been reported. For people with prediabetes, the general advice to limit added sugar and eat a balanced diet still stands, based on well-established nutrition guidance. Whether sugar substitutes help or harm blood sugar control is not yet known. Readers should not change their sweetener use based on this paper alone.
People with prediabetes, their families, and their healthcare providers may find this research relevant because it targets their condition directly. Researchers and nutrition professionals may also follow the trials closely. People who have no blood sugar concerns can treat this paper as background information. Anyone with a medical condition should speak with a doctor before changing how they use sweeteners.
The trials will take 6 weeks per participant, but the full project will require enrollment, data analysis, and publication before results are available. Reliable answers are likely to take a year or more from the start of the study. Even after results appear, follow-up studies may be needed to confirm them.
Frequently Asked Questions
Are artificial sweeteners safe for people with prediabetes?
The FDA sets acceptable daily intake limits for sweeteners, but whether they affect blood sugar in people with prediabetes is still being studied. A 2026 trial plan will test four sweeteners in adults 40 and older. Talk with your doctor about your personal situation.
Which sweeteners are being tested for blood sugar effects in prediabetes?
Researchers plan to test sucralose, aspartame, acesulfame potassium, and saccharin. Each will be compared with a group that uses no sweetener over a 6-week controlled diet in adults aged 40 and older with prediabetes.
How long will the sweetener trials last?
The planned trials run for 6 weeks total. Participants start with a 2-week lead-in diet, followed by a 4-week period where they receive the assigned sweetener or no sweetener, under a standardized eating plan.
Do sugar substitutes affect gut bacteria?
Researchers plan to measure gut microbiome changes as a secondary outcome, but this study has not reported results yet. Earlier research has raised questions about this link, and the new trials are designed to test it directly.
Want to Apply This Research?
- Track daily sweetener use by product and amount, such as the number of packets or drinks containing sucralose, aspartame, or other sweeteners. Pair this with regular fasting blood sugar readings, if your doctor has recommended them, and note the time and result of each reading.
- Read ingredient labels to identify which sweetener a product contains. Consider keeping a simple log for two weeks to see how your current sweetener use compares with your overall added sugar intake. Discuss any planned changes with your healthcare provider before making them.
- Review your sweetener log and blood sugar readings monthly, and share the trends with your doctor at regular checkups. Update your approach as new trial results are published and reviewed by health experts. Keep a record of any changes in energy, hunger, or digestion to discuss with your care team.
This article describes a research plan, not published results, so no conclusions about the safety or effects of these sweeteners should be drawn from it. Information here is for general education only and does not replace advice from a doctor, registered dietitian, or other qualified healthcare provider. If you have prediabetes or diabetes, speak with your healthcare team before changing your diet, medications, or sweetener use.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.